Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2016 (2016), Article ID 2913612, 7 pages
http://dx.doi.org/10.1155/2016/2913612
Review Article

Cellular and Molecular Pathology of Age-Related Macular Degeneration: Potential Role for Proteoglycans

1School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC 3083, Australia
2School of Pharmacy, The University of Queensland, Woolloongabba, QLD 4102, Australia
3Faculty of Health Sciences, University of Macau, Taipa, Macau
4Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510006, China
5Department of Immunology, Monash University, Melbourne, VIC 3004, Australia

Received 22 March 2016; Revised 13 June 2016; Accepted 26 June 2016

Academic Editor: Van C. Lansingh

Copyright © 2016 Othman Al Gwairi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Overview of the Economic Impact and Cost of Vision Loss in Australia 2004, http://www.cera.org.au/wp-content/uploads/2013/12/CERA_clearinsight_overview.pdf.
  2. U. Chakravarthy, T. Y. Wong, A. Fletcher et al., “Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis,” BMC Ophthalmology, vol. 10, article 31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. N. M. Bressler and S. B. Bressler, “Neovascular (exudative or ‘wet’) age-related macular degeneration,” in Retina, chapter 66, pp. 1183–1212, W.B. Saunders, London, UK, 5th edition, 2013. View at Google Scholar
  4. P. T. Harvey, “Common eye diseases of elderly people: identifying and treating causes of vision loss,” Gerontology, vol. 49, no. 1, pp. 1–11, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Resnikoff, D. Pascolini, D. Etya'ale et al., “Global data on visual impairment in the year 2002,” Bulletin of the World Health Organization, vol. 82, no. 11, pp. 844–851, 2004. View at Google Scholar · View at Scopus
  6. J. M. Seddon and L. Sobrin, “Epidemiology and risk factors for age-related macular degeneration,” in Retina, chapter 63, pp. 1134–1144, W.B. Saunders, London, UK, 5th edition, 2013. View at Google Scholar
  7. N. Ueda-Arakawa, S. Ooto, I. Nakata et al., “Prevalence and genomic association of reticular pseudodrusen in age-related macular degeneration,” American Journal of Ophthalmology, vol. 155, no. 2, pp. 260–269.e2, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Barzegar-Befroei, T. Peto, A. A. Bergen, and I. Lengyel, “Understanding the role of Bruch's membrane in CNV: the more we know about retinal structure, the better our chances of treating disease,” Retinal Physicia, vol. 9, pp. 20–25, 2012. View at Google Scholar
  9. A. U. Kishan, B. S. Modjtahedi, L. S. Morse, and P. Lee, “Radiation therapy for neovascular age-related macular degeneration,” International Journal of Radiation Oncology, Biology, Physics, vol. 85, no. 3, pp. 583–597, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. N. Y. Yang, N. Osman, M. L. Burch, and P. J. Little, “Factors affecting proteoglycan synthesis and structure that modify the interaction with lipoproteins,” Clinical Lipidology, vol. 4, no. 4, pp. 479–492, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. F. B. Sallo, E. Bereczki, T. Csont et al., “Bruch's membrane changes in transgenic mice overexpressing the human biglycan and apolipoprotein b-100 genes,” Experimental Eye Research, vol. 89, no. 2, pp. 178–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. I. E. Konstantinov, N. Mejevoi, and N. M. Anichkov, “Nikolai N. Anichkov and his theory of atherosclerosis,” Texas Heart Institute Journal, vol. 33, no. 4, pp. 417–423, 2006. View at Google Scholar · View at Scopus
  13. C. A. Curcio, M. Johnson, J.-D. Huang, and M. Rudolf, “Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins,” Progress in Retinal and Eye Research, vol. 28, no. 6, pp. 393–422, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. P. J. Little, M. L. Ballinger, and N. Osman, “Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis,” Vascular Health and Risk Management, vol. 3, no. 1, pp. 117–124, 2007. View at Google Scholar · View at Scopus
  15. G. Malek, C.-M. Li, C. Guidry, N. E. Medeiros, and C. A. Curcio, “Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy,” American Journal of Pathology, vol. 162, no. 2, pp. 413–425, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Abedi, S. Wickremasinghe, A. J. Richardson et al., “Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration,” Ophthalmology, vol. 120, no. 1, pp. 115–121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. V. Emerson and A. K. Lauer, “Current and emerging therapies for the treatment of age-related macular degeneration,” Clinical Ophthalmology (Auckland, NZ), vol. 2, pp. 377–388, 2008. View at Google Scholar
  18. P. J. Little, N. Osman, and K. D. O'Brien, “Hyperelongated biglycan: the surreptitious initiator of atherosclerosis,” Current Opinion in Lipidology, vol. 19, no. 5, pp. 448–454, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. S. N. Y. Yang, M. L. Burch, L. R. Tannock, S. Evanko, N. Osman, and P. J. Little, “Transforming growth factor-β regulation of proteoglycan synthesis in vascular smooth muscle: contribution to lipid binding and accelerated atherosclerosis in diabetes,” Journal of Diabetes, vol. 2, no. 4, pp. 233–242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. F. L. Ferris III, C. P. Wilkinson, A. Bird et al., “Clinical classification of age-related macular degeneration,” Ophthalmology, vol. 120, no. 4, pp. 844–851, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Ambati and B. J. Fowler, “Mechanisms of age-related macular degeneration,” Neuron, vol. 75, no. 1, pp. 26–39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Abdelsalam, L. Del Priore, and M. A. Zarbin, “Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression,” Survey of Ophthalmology, vol. 44, no. 1, pp. 1–29, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Zhang, Na liu, W. Zhao, X. Hou, and Y. Wang, “Choroidal neovascularization in age-related macular degeneration depends on vascular endothelial growth factor, but vascular endothelial growth factor should not be the promising treatment target,” Bioscience Hypotheses, vol. 2, no. 2, pp. 88–91, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. C. A. Curcio and M. Johnson, “Structure, function, and pathology of bruch's membrane,” in Retina, chapter 20, pp. 465–481, W.B. Saunders, London, UK, 5th edition, 2013. View at Google Scholar
  25. S. Khandhadia, V. Cipriani, J. R. W. Yates, and A. J. Lotery, “Age-related macular degeneration and the complement system,” Immunobiology, vol. 217, no. 2, pp. 127–146, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. G. Nittala, H. Ruiz-Garcia, and S. R. Sadda, “Accuracy and reproducibility of automated drusen segmentation in eyes with non-neovascular age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 53, no. 13, pp. 8319–8324, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. C. Bird, R. L. Phillips, and G. S. Hageman, “Geographic atrophy: a histopathological assessment,” JAMA Ophthalmology, vol. 132, no. 3, pp. 338–345, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. P. S. Mettu, A. R. Wielgus, S. S. Ong, and S. W. Cousins, “Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration,” Molecular Aspects of Medicine, vol. 33, no. 4, pp. 376–398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. U. Chakravarthy, J. Evans, and P. J. Rosenfeld, “Age related macular degeneration,” BMJ, vol. 340, no. 7745, pp. 526–530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. Eye-Research A: The Impact of Age-Related Macular Degeneration, 2006.
  31. Group TA-rEDsr, “The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the age-related eye disease study report number 6,” American Journal of Ophthalmology, vol. 132, no. 5, pp. 668–681, 2001. View at Publisher · View at Google Scholar
  32. Group TA-REDSR, “The Age-Related Eye Disease Study (AREDS): design implications AREDS report no. 1,” Controlled Clinical Trials, vol. 20, no. 6, pp. 573–600, 1999. View at Publisher · View at Google Scholar
  33. B. C. Toy, N. Krishnadev, M. Indaram et al., “Drusen regression is associated with local changes in fundus autofluorescence in intermediate age-related macular degeneration,” American Journal of Ophthalmology, vol. 156, no. 3, pp. 532–542.e531, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Zhang, Y.-Y. Liu, Q. Jiang et al., “Salvianolic acid A protects RPE cells against oxidative stress through activation of Nrf2/HO-1 signaling,” Free Radical Biology and Medicine, vol. 69, pp. 219–228, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. C. N. Keilhauer, L. G. Fritsche, R. Guthoff, I. Haubitz, and B. H. Weber, “Age-related macular degeneration and coronary heart disease: evaluation of genetic and environmental associations,” European Journal of Medical Genetics, vol. 56, no. 2, pp. 72–79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Hogg and U. Chakravarthy, “Age-Related Eye Disease Study (AREDS),” in Nutrition and the Eye, E. Frank, PGCertHE BSPMDFM, and Stephen Beatty MBMFMD, Eds., chapter 5.1, pp. 205–210, Butterworth-Heinemann, Edinburgh, Scotland, 2006. View at Google Scholar
  37. G. Querques and E. H. C. Souied, “The role of omega-3 and micronutrients in age-related macular degeneration,” Survey of Ophthalmology, vol. 59, no. 5, pp. 532–539, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Khan and V. Gurunadh, “Is sunlight exposure a risk factor for age related macular degeneration? A systematic review and meta-analysis,” Medical Journal Armed Forces India, vol. 70, no. 1, p. 47, 2014. View at Publisher · View at Google Scholar
  39. J. G. Elliott and N. S. Williams, “Nutrients in the battle against age-related eye diseases,” Optometry, vol. 83, no. 1, pp. 47–55, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. V. P. Mitta, W. G. Christen, R. J. Glynn et al., “C-reactive protein and the incidence of macular degeneration: pooled analysis of 5 cohorts,” JAMA Ophthalmology, vol. 131, no. 4, pp. 507–513, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. M. H. Davari, H. Gheitasi, G. Yaghobi, and B. Heydari, “Correlation between serum lipids and age-related macular degeneration: a case-control study,” Journal of Research in Health Sciences, vol. 13, no. 1, pp. 98–101, 2013. View at Google Scholar · View at Scopus
  42. F. Ambreen, W. A. Khan, N. Qureshi, and I. Z. Qureshi, “Assessment of serum lipids in patients with age related macular degeneration from Pakistan,” Journal of the Pakistan Medical Association, vol. 64, no. 6, pp. 664–669, 2014. View at Google Scholar · View at Scopus
  43. M. R. Kozlowski, “RPE cell senescence: a key contributor to age-related macular degeneration,” Medical Hypotheses, vol. 78, no. 4, pp. 505–510, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. B. P. Barnett and J. T. Handa, “Retinal microenvironment imbalance in dry age-related macular degeneration: a mini-review,” Gerontology, vol. 59, no. 4, pp. 297–306, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. C. A. Curcio, M. Johnson, J.-D. Huang, and M. Rudolf, “Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration,” Journal of Lipid Research, vol. 51, no. 3, pp. 451–467, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. R. F. Mullins, S. R. Russell, D. H. Anderson, and G. S. Hageman, “Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease,” The FASEB Journal, vol. 14, no. 7, pp. 835–846, 2000. View at Google Scholar · View at Scopus
  47. L. Wang, M. E. Clark, D. K. Crossman et al., “Abundant lipid and protein components of drusen,” PLoS ONE, vol. 5, no. 4, Article ID e10329, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. I. A. Pikuleva and C. A. Curcio, “Cholesterol in the retina: the best is yet to come,” Progress in Retinal and Eye Research, vol. 41, no. 1, pp. 64–89, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. J.-D. Huang, J. B. Presley, M. F. Chimento, C. A. Curcio, and M. Johnson, “Age-related changes in human macular Bruch's membrane as seen by quick-freeze/deep-etch,” Experimental Eye Research, vol. 85, no. 2, pp. 202–218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Klein, B. E. K. Klein, and K. L. P. Linton, “Prevalence of age-related maculopathy: the beaver dam eye study,” Ophthalmology, vol. 99, no. 6, pp. 933–943, 1992. View at Publisher · View at Google Scholar · View at Scopus
  51. T. L. van der Schaft, C. M. Mooy, W. C. de Bruijn, F. G. Oron, P. G. H. Mulder, and P. T. V. M. de Jong, “Histologic features of the early stages of age-related macular degeneration. A statistical analysis,” Ophthalmology, vol. 99, no. 2, pp. 278–286, 1992. View at Publisher · View at Google Scholar · View at Scopus
  52. C. A. Curcio and C. L. Millican, “Basal linear deposit and large drusen are specific for early age- related maculopathy,” Archives of Ophthalmology, vol. 117, no. 3, pp. 329–339, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Klein, B. E. K. Klein, M. D. Knudtson, S. M. Meuer, M. Swift, and R. E. Gangnon, “Fifteen-year cumulative incidence of age-related macular degeneration: the beaver dam eye study,” Ophthalmology, vol. 114, no. 2, pp. 253–262, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Tyl Hewitt, K. Nakazawa, and D. A. Newsome, “Analysis of newly synthesized Bruch's membrane proteoglycans,” Investigative Ophthalmology and Visual Science, vol. 30, no. 3, pp. 478–486, 1989. View at Google Scholar · View at Scopus
  55. S. N. Y. Yang, M. L. Burch, R. Getachew, M. L. Ballinger, N. Osman, and P. J. Little, “Growth factor-mediated hyper-elongation of glycosaminoglycan chains on biglycan requires transcription and translation,” Archives of Physiology and Biochemistry, vol. 115, no. 3, pp. 147–154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. M. L. Ballinger, J. Nigro, K. V. Frontanilla, A. M. Dart, and P. J. Little, “Regulation of glycosaminoglycan structure and atherogenesis,” Cellular and Molecular Life Sciences, vol. 61, no. 11, pp. 1296–1306, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. A. U. Kishan, B. S. Modjtahedi, E. N. Martins, S. P. Modjtahedi, and L. S. Morse, “Lipids and age-related macular degeneration,” Survey of Ophthalmology, vol. 56, no. 3, pp. 195–213, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Höhn, J. König, and T. Grune, “Protein oxidation in aging and the removal of oxidized proteins,” Journal of Proteomics, vol. 92, pp. 132–159, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. Y.-M. Huang, S.-F. Yan, L. Ma et al., “Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration,” Nutrition, vol. 29, no. 2, pp. 387–392, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. M. L. Burch, S. N. Y. Yang, M. L. Ballinger, R. Getachew, N. Osman, and P. J. Little, “TGF-β stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2,” Cellular and Molecular Life Sciences, vol. 67, no. 12, pp. 2077–2090, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. M. L. Ballinger, N. Osman, K. Hashimura et al., “Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo,” Journal of Cellular and Molecular Medicine, vol. 14, no. 6, pp. 1408–1418, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. M. L. Burch, M. L. Ballinger, S. N. Y. Yang et al., “Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor βtype I receptor,” Journal of Biological Chemistry, vol. 285, no. 35, pp. 26798–26805, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. T. D. L. Keenan, S. J. Clark, R. D. Unwin, L. A. Ridge, A. J. Day, and P. N. Bishop, “Mapping the differential distribution of proteoglycan core proteins in the adult human retina, choroid, and sclera,” Investigative Ophthalmology & Visual Science, vol. 53, no. 12, pp. 7528–7538, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. S. J. Clark, T. D. L. Keenan, H. L. Fielder et al., “Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera,” Investigative Ophthalmology & Visual Science, vol. 52, no. 9, pp. 6511–6521, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Koike, T. Izumikawa, B. Sato, and H. Kitagawa, “Identification of phosphatase that dephosphorylates xylose in the glycosaminoglycan-protein linkage region of proteoglycans,” The Journal of Biological Chemistry, vol. 289, no. 10, pp. 6695–6708, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Getachew, M. L. Ballinger, M. L. Burch et al., “PDGF β-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL,” Endocrinology, vol. 151, no. 9, pp. 4356–4367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. T. D. L. Keenan, C. E. Pickford, R. J. Holley et al., “Age-dependent changes in heparan sulfate in human Bruch's membrane: implications for age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 55, no. 8, pp. 5370–5379, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. J. L. Haines, M. A. Hauser, S. Schmidt et al., “Complement factor H variant increases the risk of age-related macular degeneration,” Science, vol. 308, no. 5720, pp. 419–421, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. G. S. Hageman, D. H. Anderson, L. V. Johnson et al., “A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 20, pp. 7227–7232, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. P. J. Little, M. A. Rostam, T. J. Piva et al., “Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells,” Journal of Pharmacy and Pharmacology, vol. 65, no. 7, pp. 1055–1063, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. M. E. Ivey and P. J. Little, “Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways,” Thrombosis Research, vol. 123, no. 2, pp. 288–297, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Dadlani, M. L. Ballinger, N. Osman, R. Getachew, and P. J. Little, “Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle,” The Journal of Biological Chemistry, vol. 283, no. 12, pp. 7844–7852, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Inatani and H. Tanihara, “Proteoglycans in retina,” Progress in Retinal and Eye Research, vol. 21, no. 5, pp. 429–447, 2002. View at Publisher · View at Google Scholar · View at Scopus